Bernstein Liebhard LLP Investigating Diabetes Drug Lawsuits Involving Byetta, Januvia, Victoza and Similar Medications


New York, New York (PRWEB) June 16, 2013

The nationwide law firm of Bernstein Liebhard LLP is investigating diabetes drug lawsuits on behalf of individuals treated with Byetta, Januvia, Victoza and other medications recognized as incretin mimetics, and who have been diagnosed with pancreatitis, pancreatic cancer or thyroid cancer. Type II diabetics who had been treated with an incretin mimetic and who have been diagnosed with a single of these illnesses may be entitled to compensation for health-related bills, lost wages, discomfort and suffering and other damages. Medicines integrated in the Firms diabetes drug lawsuit investigation incorporate:&#13

&#13

New York-Based Debt Collection Agency CEO Issues Response to the Rise in the States Debt Collection Lawsuits


Bohemia, NY (PRWEB) June 16, 2013

On June 16, 2013, John Monderine, CEO of New York-primarily based accounts receivable collection agency Speedy Recovery Solution, comments on an write-up explaining how the number of debt collection lawsuits are rapidly rising due to collectors sewer service tactics.

&#13

According to a June 11, 2013 report from Business Week, How Debt Collectors Ruin Credit Reports With Sewer Service, the New Economy Project reports in 2011 there had been upwards of 200,000 debt collection lawsuits in New York State. Debt collectors have been capable to win judgments by default since borrowers failed to show up in court due to sewer service tactics. Creditors who engage in these tactics send subpoenas down sewer drains rather than to the recipients.

&#13

Men and women discover that these unknown default judgments come back to haunt them when applying for a loan. Internet designer Brian Pindell explains the difficulty in attaining a disaster loan from the Tiny Enterprise Administration: The SBA denied my application since of two judgments that have been apparently on my credit report. Pindell was never ever notified of either judgment, and received no subpoenas.

&#13

John Monderine, CEO of Speedy Recovery Solution, one of New Yorks premier commercial debt collection agencies, says that totally free credit checks can support decrease the probabilities of becoming a victim of unethical techniques. Free of charge credit checks can aid consumers discover out if they are becoming subjected to these crass tactics otherwise any blip on an individuals credit report will show up when least anticipated. At that point, there is quite small a consumer can do to mitigate the scenario. If a default judgment is ascertained swiftly, consumers can create to credit bureaus explaining why theyre becoming judged. Supplied their credit reports are clean, judgments will most probably be disregarded.

&#13

Default judgments are quite difficult to overturn by modest enterprise owners who find themselves in such as a predicament, as former collection agency owner, Michelle Dunn explains. You can no longer dispute the debt, she says. If its a small claims quantity, you paythats what most individuals do. If its a bigger amount, you can get an attorney, but a judgment genuinely is a final judgment.

&#13

Founded in 2006, Rapid Recovery Solution, Inc. is headquartered at the highest point of lovely Extended Island. Speedy Recovery Collection Agency is committed to recovering your funds. We think that each debtor has the capability to pay if motivated appropriately. We DO NOT alienate the debtors we attempt to align with them and offer a quantity of ways to resolve not only your debt but also all their debts.

&#13
&#13
&#13
&#13
&#13

Find Far more Administrator Press Releases

Biomet Hip Lawsuits Mount in Federal Biomet M2a Magnum Hip Replacement Litigation, Bernstein Liebhard LLP Reports


New York, New York (PRWEB) June 16, 2013

Biomet hip lawsuit claims alleging severe injuries due to the Biomet M2a Magnum Hip Replacement Technique continue to mount in a federal multidistrict litigation underway in U.S. District Court, Northern District of Indiana, Bernstein Liebhard LLP reports. According to an MDL Statistics Report issued on May possibly 14th by the U.S. Judicial Panel on Multidistrict Litigation (JPML), at least 308 Biomet hip replacement claims have been filed in the federal litigation given that it was established in October 2012. (In re: Biomet M2a Magnum Hip Implant Goods Liability Litigation MDL No. 2391)

&#13

We continue to hear from people fitted with metal-on-metal hip implants, including the Biomet M2a Magnum, who allegedly suffered significant complications linked with the failure of their device. It is not surprising that the number of Biomet hip replacement lawsuits filed in this litigation has currently surpassed 300, says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and healthcare devices. The Firm is actively filing Biomet hip lawsuits in the federal multidistrict litigation, and continues to supply totally free and confidential case evaluations to men and women who might have been injured by Biomet M2a Magnum implants.

&#13

Biomet Hip Replacement Lawsuits&#13

According to court documents, Biomet hip lawsuits allege the metal-on-metal style of the Biomet M2a Magnum implant is prone to put on, and can create higher metal ion levels. This could trigger sufferers to endure metallosis and other adverse tissue reactions, premature device failure and other complications that necessitate revision surgery to get rid of and replace the device. When the multidistrict litigation was established by the JPML in October 2011, 66 Biomet hip replacement claims had been pending in federal courts all through the U.S.

&#13

The U.S. Food &amp Drug Administration (FDA) has been investigating metal-on-metal hip implants because February 2011, amid concerns that metal ions shed from the hips can outcome in metallosis, adverse neighborhood tissue reactions, and early failure. In January, the agency issued new guidance for hip replacement patients fitted with these devices that suggested metal ion testing in those experiencing symptoms of hip implant failure. The FDA also mentioned it had proposed a new rule that would make all-metal hips ineligible for 510(k) approvals, a process which permitted metal-on-metal hips to come to market without having very first undergoing human clinical trials.*

&#13

Biomet M2a Magnum hip recipients who allegedly suffered injuries as a result of the device might be entitled to compensation for their healthcare expenses, lost wages and discomfort and suffering. To understand a lot more about the litigation surrounding this and other metal-on-metal hip implants, please visit Bernstein Liebhard LLPs site, or get in touch with 1 our attorneys today at 800-511-5092.

&#13

*fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/MetalonMetalHipImplants/ucm241604.htm

&#13

About Bernstein Liebhard LLP &#13

Bernstein Liebhard LLP is a New York-primarily based law firm exclusively representing injured persons in complex person and class action lawsuits nationwide because 1993, such as those who have been harmed by hazardous drugs, defective healthcare devices and consumer goods. The firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the best plaintiffs firms in the nation, for the past 10 consecutive years.

&#13

Bernstein Liebhard LLP &#13

10 East 40th Street &#13

New York, New York 10016 &#13

800-511-5092

&#13

Lawyer Marketing.

LawyersandSettlements.com Reports A 70 Percent Spike In Mortgage Complaints More than Final Year Lawsuits Alleging Bank Misconduct Continue To Be Filed


Santa Cruz, Calif. (PRWEB) October ten, 2012

While the aftermath of the sub-prime mortgage crisis has seen a quantity of massive U.S. banks defending themselves against charges of misconduct, new information reported by LawyersandSettlements.com indicates consumers are still getting impacted by the crisis. Mortgage-associated complaints submitted to the legal news site have continued to improve year-more than-year as readers continue to seek out legal aid in dealing with foreclosures and discriminatory lending practices.

&#13

LawyersandSettlements.com has reported a 70 % jump in mortgage complaints from January through June 2012 compared with the identical period a year ago. In addition, mortgage complaints to the site have risen 114 percent so far this year vs. a comparable period 5 years ago, in 2007. Complaints are submitted to the legal news web site in order to seek legal aid.

&#13

There are three main categories for which mortgage complaints to LawyersandSettlements.com continue to be submitted:

&#13

1. Predatory and Discriminatory Mortgage Lending. One particular instance of a mortgage lawsuit involving discrimination was the current U.S. Division of Justice case involving Wells Fargo (United States v. Wells Fargo Bank, NA (D.D.C.)). The case was the second biggest fair lending settlement in the departments history. As part of the discriminatory lending settlement, Wells Fargo agreed to pay $ 175 million to settle allegations that it charged African-Americans and Hispanics greater costs and prices on mortgages than for Caucasian borrowers with similar credit profiles. Wells Fargo stated its intent to settle the mortgage lawsuit was to keep away from contested litigation, and that it treated all consumers fairly without regard to race or ethnicity. This, in spite of the massive numbers of discriminatory lending victims uncovered by a government investigation.

&#13

In addition to racial discriminatory lending complaints, LawyersandSettlements.com has also received predatory lending complaints from seniors who allege they have been targeted with items ranging from mortgages with an introductory low price (that rises substantially later on), to reverse mortgages that eat up a homeowner’s equitysometimes without the homeowner fully realizing the correct supply of the nonetheless welcomed earnings.

&#13

Wells Fargo was the target of a reverse mortgage lawsuit final year in Chandler v. Wells Fargo &amp Co., Case No. 11-cv-03831, U.S. District Court, Northern District of California (San Francisco). The mortgage lawsuit, which was filed as a class action, is nevertheless pending. It accuses Wells Fargo of disregarding federal rules on reverse mortgages and forcing homeowners into foreclosure instead of giving heirs a likelihood to buy the residences.

&#13

2. Foreclosures. Foreclosure complaints comprise the second category contributing to the rise in mortgage-related complaints submitted at LawyersandSettlements.com. A single foreclosure lawsuit recently filed by Jay Fenello of Woodstock, Georgia (Fenello v. Bank of America, Case No. 1:11-cv-04139-WSD, U.S. District Court, Northern Division, Georgia) alleges Bank of America has been acting in violation of the terms for foreclosure procedure set forth in U.S. et al v. Bank of America Corp., et al (Case No. 1:12-cv-00361-RMC, U.S. District Court, D.C.). In the filing, Fenello’s allegations center on attempts made by Bank of America to foreclose on his home whilst engaging in illegal and unethical practices, including misrepresenting eligibility criteria for loan modifications.

&#13

3. Investment Loss Stemming from Mortgage-backed Securities. The failure of mortgage-backed securities stemming from the sub-prime mortgage meltdown of a couple of years ago has left numerous investors with substantial losses right after becoming advised that such securities have been low-, or even no-danger investments. In re Lehman Brothers Mortgage-based Securities Litigation, Case No. 08-CV-6762, U.S. District Court, Southern District of New York, plaintiffs in the class action lawsuit have been awarded $ 40 million in damages. LawyersandSettlements.com continues to obtain complaints with regards to mortgage-backed safety monetary losses from its readership.

&#13

About LawyersandSettlements.com&#13

LawyersandSettlements.com provides extensive legal news and crucial info for these impacted by as soon as-in-a-lifetime circumstances involving health-related device lawsuits, individual injury, defective products, California overtime and labor problems or a host of other people. Readers seeking legal assist can request it by completing a form which is distributed to attorneys specializing in these instances. Trial attorneys utilize the internet site to hold abreast of hot legal troubles and settlements as properly as connect with potential customers.

&#13

About On the internet Legal Media&#13

On-line Legal Media owns and operates internet sites delivering information for the basic public and the legal neighborhood. LawyersandSettlements.com, founded in 2001, is an on the web legal news publication with over 2.5 million visitors annually and hundreds of thousands of requests for lawyer assist from its readership. OnlineLegalMarketing.com serves as a portal for trial attorneys to network and to market their firms to other attorneys and legal experts. HealthEffectsOfAsbestos.com gives up-to-date resources and news for those suffering from asbestos exposure and mesothelioma. On the internet Legal Media is primarily based in Santa Cruz, California.

&#13
&#13
&#13
&#13
&#13

A lot more Loan Modification Press Releases

Actos Lawsuits: Bernstein Liebhard LLP Notes Far more Than 1,500 Situations Now Filed in Federal Litigation


New York, New York (PRWEB) June 02, 2013

Court documents indicate that more than 1,500 Actos lawsuit claims alleging bladder cancer are now pending in a federal litigation underway in the U.S. District Court, Western District of Louisiana, Bernstein Liebhard LLP reports.

&#13

According to court records, an update on the number of Actos filings in the federal litigation was presented at a May 23rd status conference, which also addressed troubles associated to the status of discovery and the scheduling of bellwether trials in the litigation. Lawsuits filed in this proceeding allege the possible for long-term use of Actos, a type two diabetes drug manufactured by Takeda Pharmaceuticals, to trigger or worsen bladder cancer. (In re: Actos Solution Liability Litigation, MDL No. 2299)

&#13

As we continue to receive inquiries about prospective Actos lawsuits from individuals who allege extended-term use of the drug triggered their bladder cancer, we are pleased to see this litigation moving forward, says Bernstein Liebhard LLP, nationwide law firm representing the victims of defective drugs and health-related devices. The Firm is at the moment offering free Actos bladder cancer lawsuit evaluations to individuals who developed bladder cancer right after utilizing the medication for an extended period of time.

&#13

Actos Bladder Cancer Lawsuit Allegations

&#13

The federal multidistrict litigation for Actos bladder cancer lawsuits was produced in the U.S. District Court, Western District of Louisiana in December 2011, after the U.S. Meals and Drug Administration issued an alert warning the public that long-term use of the medication might increase a individuals threat for establishing bladder cancer.* There are now 1,500 instances pending in in the Western District of Louisiana, exactly where the proceeding continues to move forward. According to court documents, the next status conference in the litigation has been scheduled for June 20, 2013. Court records further indicate the first bellwether trials for the Actos bladder cancer litigation have been scheduled as effectively, with the initial trial is slated to begin on January 27, 2014, with the second to adhere to on April 14, 2014.

&#13

In addition to the federal litigation, Bloomberg.com reported on May 1st that claims filed more than the medication employed to manage blood-sugar levels in type 2 diabetes sufferers are pending in state litigations in Illinois and California.**

&#13

Individuals who took Actos and developed bladder cancer following lengthy-term use of the drug may possibly be eligible to seek compensation for medical bills, lost wages, pain and suffering and other damages. Understand more about how to file an Actos lawsuit by going to Bernstein Liebhard LLPs web site or by calling a single of the Firms Actos lawyers at 800-511-5092.

&#13

*FDA, June 15, 2011 fda.gov/drugs/drugsafety/ucm259150.htm&#13

**bloomberg.com/news/2013-05-01/takeda-gets-six-five-million-diabetes-drug-verdict-thrown-out.html

&#13

About Bernstein Liebhard LLP

&#13

Bernstein Liebhard LLP is a New York-primarily based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, which includes these who have been harmed by harmful drugs, defective health-related devices and customer goods. The firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the top plaintiffs firms in the nation, for the previous ten consecutive years.

&#13

Bernstein Liebhard LLP&#13

10 East 40th Street&#13

New York, New York 10016&#13

800-511-5092

&#13

Attorney Advertising.

Vaginal Mesh Lawsuits Move Forward, as Bernstein Liebhard LLP Notes New Pretrial Order in Federal Transvaginal Mesh Litigation


New York, New York (PRWEB) May possibly 30, 2013

Thousands of vaginal mesh lawsuit claims continue to move forward in federal litigations now underway in U.S. District Court, Southern District of West Virginia, Bernstein Liebhard LLP reports. According to a Pretrial Order issued by the Court on May possibly 29th, parties in the litigations have reached an agreement regarding the delayed filing of claims and the application of the statute of limitations. According to the Order, the agreement will apply to 4 litigations underway in the Southern District of West Virginia: American Health-related Systems, Inc., Pelvic Repair Systems Items Liability Litigation (MDL No. 2325) In re: Boston Scientific Corp., Pelvic Repair Systems Items Liability Litigation (MDL No. 2326) In re: C.R. Bard, Inc., Pelvic Repair Systems Products Liability Litigation (MDL No. 2187) and In re: Ethicon, Inc., Pelvic Repair Systems Goods Liability Litigation ( MDL No. 2327). Bernstein Liebhard LLP partner, Jeffrey S. Grand, serves on the Plaintiffs Steering Committee in all of these proceedings.

&#13

This Order will make certain that vaginal mesh lawsuits are filed in an effective manner in these 4 proceedings. We are pleased to see these situations progressing, as we continue to hear from ladies who allegedly suffered significant vaginal mesh complications following surgery to treat pelvic organ prolapse and pressure urinary incontinence, says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and health-related devices. The Firm is at present representing hundreds of girls in state and federal courts who allegedly suffered mesh erosion, pain, scarring, infection and other serious vaginal mesh complications.

&#13

Vaginal Mesh Complications&#13

Pelvic mesh devices employed to treat pelvic organ prolapse and pressure urinary incontinence have been the topic of a U.S. Meals &amp Drug Administration (FDA) security assessment because October 2008, when the agency warned that it had received more than 1,000 vaginal mesh complication reports for the duration of a 3-year period. In July 2011, the FDA changed its stance on the frequency of injuries associated with prolapse repair, stating it no longer regarded these complications to be rare. At that time, the agency revealed it had received far more than two,800 reports of vaginal mesh injuries because its 2008 communication.*

&#13

Court documents indicate that thousands of women have given that filed transvaginal mesh lawsuits, all of which allege the manufacturers of the devices have been negligent in designing the items, and failed to warn customers of their significant risks. Thousands of added transvaginal mesh claims involving goods marketed by Ethicon Inc. and C.R. Bard have been consolidated in New Jersey Superior Court, Atlantic County, exactly where Bernstein Liebhard LLP partner, Jeffrey, S.. Grand is serving as Co-Liaison Counsel. (In re: Pelvic Mesh Litigation/Bard, No. L-6339-ten, and In re: Pelvic Mesh/Gynecare Litigation, No. 6341-ten) He also served on the trial team in the litigations initial Ethicon mesh trial, which concluded with an award of far more than $ 11 million, including punitive damages, to the Plaintiff. (Gross v. Gynecare Inc., Atl-L-6966-ten, Superior Court of Atlantic County, New Jersey).

&#13

Victims of alleged vaginal mesh complications could be entitled to compensation for their healthcare bills, discomfort and suffering, and other injuries. A wealth of info relating to transvaginal mesh lawsuits can be located at Bernstein Liebhard’s web site. To learn a lot more, please get in touch with 800-511-5092.

&#13

*fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/UroGynSurgicalMesh/default.htm

&#13

About Bernstein Liebhard LLP &#13

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex person and class action lawsuits nationwide since 1993, which includes these who have been harmed by unsafe drugs, defective health-related devices and consumer products. The firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the top plaintiffs firms in the nation, for the past ten consecutive years.

&#13

Bernstein Liebhard LLP &#13

ten East 40th Street &#13

New York, New York 10016 &#13

800-511-5092

&#13

Lawyer Marketing.

Biomet Hip Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Upcoming Case Management Conference in Federal Biomet Hip Replacement Litigation


New York, New York (PRWEB) May 26, 2013

The federal litigation established for Biomet hip lawsuits continues to move forward in U.S. District Court, Northern District of Indiana, Bernstein Liebhard LLP reports. According to the Courts website, the litigations next Case Management Conference has been scheduled for June 17th. All of the lawsuits pending in the Biomet hip replacement litigation allege the metal-on-metal design of the Biomet M2a Magnum hip can generate high levels of metal ions, leading to metallosis in the surrounding tissue and early failure of the device. (In re: Biomet M2a Magnum Hip Implant Products Liability Litigation MDL No. 2391)

Our Firm is already representing clients in the federal Biomet hip replacement litigation, and continues to receive inquiries from Biomet M2a hip recipients who have allegedly suffered serious and debilitating complications related to the metal-on-metal device. We are pleased to see this proceeding moving forward, says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm continues to offer free Biomet hip lawsuit evaluations to individuals allegedly injured by the Biomet M2a hip.

Biomet Hip Lawsuits

Biomet M2a Magnum Hip Replacements are metal-on-metal hip implants, which consist of a ball and cup made from a chromium-cobalt alloy. As of March 2013, court documents indicated that more than 140 Biomet hip lawsuits were pending in the federal Biomet hip replacement litigation. All federally-filed Biomet hip lawsuits were ordered transferred to the Northern District of Indiana in October 2012, in anticipation of a large number of claims.

This past January, the U.S. Food & Drug Administration (FDA) warned that metal debris shed as metal-on-metal hip components wear may accumulate to dangerous levels in the body. This occurrence can result in bone and/or soft tissue damage in the area surrounding the implant and joint, leading to adverse local tissue reactions, premature device failure, and even additional symptoms or illnesses elsewhere in the body. Among other things, the FDA cautioned doctors to consider metal ion testing if patients are experiencing symptoms of hip implant failure. According to the January announcement, the FDA is considering implementing new regulations for metal-on-metal hip implants that would make the devices ineligible for 510(k) clearances, which allowed such implants to come to market without human clinical trials.*

Alleged victims of Biomet hip replacement problems, including metallosis, hip implant failure, and other serious complications may be entitled to compensation for their medical bills, lost wages, pain and suffering, and other damages. A wealth of information about Biomet hip lawsuits is available at Bernstein Liebhards website. For additional information, please contact one of our attorneys today by calling 800-511-5092.

*fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/MetalonMetalHipImplants/ucm241604.htm

About Bernstein Liebhard LLP

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the top plaintiffs firms in the country, for the past 10 consecutive years.

Bernstein Liebhard LLP

10 East 40th Street

New York, New York 10016

800-511-5092

ATTORNEY ADVERTISING.

Pradaxa Lawsuits Mount, as Filings in Federal Pradaxa Side Effect Litigation Exceed 800, Bernstein Liebhard LLP Reports


New York, New York (PRWEB) May 25, 2013

Pradaxa lawsuits filed on behalf of patients who allegedly suffered serious, life-threatening episodes of internal bleeding while using the blood thinner continue to mount in a federal litigation underway in U.S. District Court, Southern District of Illinois, Bernstein Liebhard LLP reports. According to a posting on the Courts website, 818 Pradaxa side effect claims had been filed in the litigation as of May 24, 2013. Thats up from 705 claims reported by the Court on May 15th. ( In Re: Pradaxa (Dabigatran Etexilate) Products Liability Litigation MDL No. 2385)

We are not surprised that the Pradaxa lawsuits filed in this litigation are increasing at such a rapid rate. Our Firm receives inquiries on a regular basis from Pradaxa patients who have allegedly suffered serious instances of internal bleeding, says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is offering free Pradaxa side effect lawsuit evaluations to anyone who suffered internal bleeding while using the blood thinner.

Pradaxa Side Effects

Plaintiffs with claims pending in the Pradaxa side effect litigation allege that Boehringer Ingelheim failed to adequately warn that there is no readily-available antidote for internal bleeding that is sometimes associated with use of the blood thinner. According to a Bloomberg.com report published in December 2012, regulators in several countries have issued alerts regarding Pradaxas potential to cause dangerous internal bleeding in some patients.* Pradaxa was supposed to be an improvement over warfarin, a decades old blood thinner. However, warfarin bleeding can be stopped via the administration of vitamin K, while dialysis is the only available treatment for this Pradaxa side effect.